VESSEL DISEASES IN INFECTION COVID-19 IN PATIENTS WITHFATAL CASES
Main Article Content
Abstract
The aim – to investigate the risk factors of fatal case in COVID-19 and to illustrate by clinical observation.
The materials and methods. There has been carried out the retrospective study analysis of patients, diagnosed with fatal cases of infection COVID-19, confirmed by PCR test for detection of RNA virus SARS-Cov2 and/or by domestic tests of Vector-best for specific antibodies IgM and IgG subclasses of diagnostic level. There has been represented the self-reporting case of clinical observation.
The results. All the patients have not been vaccinated. More than half of the patients are female. About 88.9 % of patients are above 60 years of age. Nearly all of the patients have got the comorbid conditions: hypertensive disease, diabetes mellitus, the chronic nervous system disorders (cerebral dysfunction, cerebrovascular disease, encephalopathy), obesity, chronic heart disease and others. There have been diagnosed the signs of chronic vessel disease of various organs (atherosclerosis, diabetic angiopathy) in most of patients. The acute vascular disorders (vasculopathy, microthrombosis, destructive thrombovasculitis) have been detected in internals in all patients.
The conclusion. The risk factors of fatal case in infection COVID-19 are cardiovascular system diseases, diabetes mellitus, vascular diseases of nervous system, obesity and their combination, the patients above the age of 60, female, absence of vaccination. This category of patients needs to be carefully monitored for inflammatory markers and for coagulogram in order to correct timely the treatment activities.
Keywords
Article Details
Information about financing and conflict of interests
The authors declare that they have no apparent or potential conflicts of interest related to the publication of this article.
This work is licensed under a Creative Commons Attribution 4.0 License.
How to Cite
References
Song Z, Xu Y, Bao L, Zhang L, Yu P, Qu Y, et al. From SARS to MERS, thrusting coronaviruses into the spotlight. Viruses. 2019; 11(1): 59. doi: 10.3390/v11010059
Hui DS, Zumla A. Severe acute respiratory syndrome. Historical, epidemiologic, and clinical features. Infect Dis Clin North Am. 2019; 33(4): 869-889. doi: 10.1016/j.idc.2019.07.001
Zayrat'yants OV, Samsonova MV, Chernyaev AL, Mishnev OD, Mikhaleva LM, Krupnov NM, Kalinin DV. Pathological anatomy COVID-19: experience of 2000 autopsies. Russian Journal of Forensic Medicine. 2020; 6(4): 10-23. Russian (Зайратьянц О.В., Самсонова М.В., Черняев А.Л., Мишнев О.Д., Михалёва Л.М., Крупнов Н.М., Калинин Д.В. Патологическая анатомия COVID-19: опыт 2000 аутопсий //Судебная медицина. 2020. Т. 6, № 4. С. 10-23.) doi: 10.19048/fm340
Mao L, Jin H, Wang M. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020; 77: 1-9
Jayarangaiah A, Kariyanna PT, Chen X, Jayarangaiah A, Kumar A. COVID-19-Associated Coagulopathy: An Exacerbated Immunothrombosis Response. Clin Appl Thromb Hemost. 2020; 26: 1076029620943293. doi: 10.1177/1076029620943293
Colling ME, Kanthi Y. COVID-19-associated coagulopathy: An exploration of mechanisms. Vasc Med. 2020; 25: 471-478. doi: 10.1177/1358863X20932640
Varga S, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. Endothelial cell infection and endotheliitis in CoVID-19. Lancet. 2020; 395(10234): 1417-1418. doi: 10.1016/S0140-6736(20)30937-5
Qin C, Zhou L, Hu Z, et al. Dysregulation of immune response in patients with Coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020; 71(15): 762-768. doi: 10.1093/cid/ciaa248
Zayrat'yants OV, Samsonova MV, Mikhaleva LM et al. Pathological anatomy of COVID-19: Atlas /ed. by OV Zayrat'yants. M., 2020. 140 p. Russian (Зайратьянц О.В., Самсонова М.В., Михалева Л.М. и др. Патологическая анатомия COVID-19: Атлас /под общей ред. О.В. Зайратьянца. М., 2020. 140 с.)
Wolfel R, Corman VM, Guggemos W, еt al. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020; 581(7809): 465-469. doi: 10.1038 / s41586-020-2196-x
Қozhasheva AE, Belesbek SO, Abdimitova DZh, Saken BM, Borikhodzhaeva AP, Baymukhambetova ZB. COVID-19 and stroke: possible causes and pathogenesis (review). Vestnik KAZNMU. 2021; 1: 103-106. Russian (Қожашева А.Е., Белесбек С.О., Абдимитова Д.Ж., Сакен Б.М., Бориходжаева А.П., Баймухамбетова З.Б. COVID-19 и инсульт: возможные причины и патогенез развития (литературный обзор) //Вестник КАЗНМУ. 2021. № 1. С. 103-106)
Shen N, Zhu Y, Wang X, et al. Characteristics and diagnosis rate of 5,630 subjects receiving SARS-CoV-2 nucleic acid tests from Wuhan, China. JCI Insight. 2020; 5(10): e137662. doi: 10.1172/jci.insight.137662
CDC COVID-19 Response Team. Severe outcomes among patients with coronavirus disease 2019 (COVID-19): United States, February 12 - March 16, 2020. MMWR Morb Mortal Wkly Rep. 2020; 69(12): 343-346
Aggarwal G, Cheruiyot I, Aggarwal S, et al. Association of cardiovascular disease with coronavirus disease 2019 (COVID-19) severity: a meta-analysis. Curr Probl Cardiol. 2020; 45(8): 100617. doi: 10.1016/j.cpcardiol.2020.100617
Pranata R, Lim MA, Huang I, et al. Hypertension is associated with increased mortality and severity of disease in COVID-19 pneumonia: a systematic review, meta-analysis and meta-regression. J Renin Angiotensin Aldosterone Syst. 2020; 21(2): 1470320320926899
Morugova TV, Shamigulov FB, Chakryan SA, Timerbulatov ShV, Avzaletdinova DSh, Morugova IV, Khamidullina ZZ. New coronavirus infection (COVID-19) in diabetes patients. Meditsinskiy vestnik Bashkortostana. 2020; 15(3): 27-30. Russian (Моругова Т.В., Шамигулов Ф.Б., Чакрян С.А., Тимербулатов Ш.В., Авзалетдинова Д.Ш., Моругова И.В., Хамидуллина З.З. Течение новой коронавирусной инфекции (COVID-19) на фоне сахарного диабета //Медицинский вестник Башкортостана. 2020. Т. 15, № 3(87). С. 27-30)
Emami A, Javanmardi F, Pirbonyeh N, et al. Prevalence of underlying diseases in hospitalized patients with COVID-19: a systematic review and meta-analysis. Arch Acad Emerg Med. 2020; 8(1): e35
Pizova NV, Pizov NA, Skachkova OA, Sokolov MA, Izmaylov IA, Taramakin RB. Acute cerebral circulatory disorders and coronavirus disease. Meditsinskiy sovet. 2020; (8): 20-27. Russian (Пизова Н.В., Пизов Н.А., Скачкова О.А., Соколов М.А., Измайлов И.А., Тарамакин Р.Б. Острые нарушения мозгового кровообращения и коронавирусная болезнь //Медицинский совет. 2020. № 8. С. 20-27.) doi: 10.21518/2079-701X-2020-8-20-27
Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020; 18(4): 844-847. doi: 10.1111/jth.14768
Shirokov E.A. COVID-assoiciated ischemic stroke. Klinicheskaya meditsina. 2020; 98(5): 375-377. Russian (Широков Е.А. COVID-ассоциированный ишемический инсульт //Клиническая медицина. 2020. Т. 98, № 5. С. 375-377.) doi: 10.30629/0023-2149-2020-98-5-375-377
Cao J, Hu X, Cheng W, Yu L, Tu WJ, Liu Q. Clinical features and short-term outcomes of 18 patients with corona virus disease 2019 in intensive care unit. Intensive Care Med. 2020; 46: 851-853
Khandelwal P, Al-Mufti F, Tiwari A, et al. Incidence, characteristics and outcomes of large vessel stroke in COVID-19 cohort: an international multicenter study. Neurosurgery. 2021; 89(1): E35-E41. doi: 10.1093/neuros/nyab111